Cue Health to Participate at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Cue Health, a healthcare technology company (Nasdaq: HLTH), will participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 13, 2024.
01/31/2024 - 04:01 PM
SAN DIEGO --(BUSINESS WIRE)-- Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that its management team will participate at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Tuesday, February 13, 2024.
About Cue Health
Cue Health Inc. (Nasdaq: HLTH) is a healthcare technology company that uses diagnostic-enabled care to empower people to live their healthiest lives. The Cue Health platform offers individuals and healthcare providers convenient and personalized access to lab-quality diagnostic tests at home and at the point-of-care, as well as on-demand telehealth consultations and treatment options for a wide range of health and wellness needs. Cue’s customers include federal and state public sector agencies and the private sector, which includes healthcare providers, enterprises, and individual consumers. Cue received De Novo authorization from the U.S. Food and Drug Administration (FDA) for its COVID-19 test, which became the first home use respiratory test to receive this FDA approval. Cue also received Emergency Use Authorization from the FDA for its molecular Mpox test at the point-of-care. Cue, founded in 2010, owns over 100 patents and is headquartered in San Diego . For more information, please visit www.cuehealth.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20240131854025/en/
Press
press@cuehealth.com
Investors
caroline.corner@westwicke.com
Source: Cue Health Inc.
What is the ticker symbol for Cue Health?
The ticker symbol for Cue Health is HLTH.
When is Cue Health participating in the BTIG conference?
Cue Health will participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 13, 2024.
HLTH Rankings
#5482 Ranked by Stock Gains
HLTH Stock Data
Industry
Surgical and Medical Instrument Manufacturing
Sector
Manufacturing
Tags
Health Services, Hospital/Nursing Management
About HLTH
cue, a revolutionary device for tracking health information at the molecular level. for the first time, consumers can track 5 key health and lifestyle indicators: inflammation, vitamin d, fertility, influenza, and testosterone in just minutes, at home. cue sends the data via bluetooth 4.0 to the user's smartphone, where the free cue app reveals the interplay of activity, food, and sleep shaping the user at a molecular level. by simply adding a noninvasive droplet of saliva, blood, or nasal swab, you can access deep information about your body only previously available from a lab -- on demand and on your schedule. interactive charts put you in touch with your health, making it easy to discover new trends, monitor your progress, and share it with the people who matter most. cue also features life feed, an incredible new smartphone-based way to visualize the daily effect of activity, food, and sleep on your molecular health. cue makes research-based recommendations for foods proven to sup
